INSIGHTS ON CLINICAL TRIAL PARTNERING

• CRO Solutions Expo: Clinical Research Is A Delicate Ecosystem

  Elevate your complex oncology program by partnering with a team that delivers transparent communication, deep expertise, and the focused attention emerging and midsized biotechs need to succeed.

• Site Management Support To Investigational Sites

  Rare disease trials demand specialized site support. Explore how tailored site management practices can improve consistency, data quality, and patient engagement in complex clinical studies.

• Specialized Site Network For Early-Phase Oncology Success

  Early-phase oncology trials are complex, demanding precision, rapid execution, and specialized expertise. Yet, too often, the operational burden falls on clinical sites―already overworked and stretched thin. Within large, volume-driven CRO networks, this creates a system that prioritizes scale over quality, offering minimal site support, delaying timelines, and ultimately compromising trial outcomes.

• 3 Reasons Sponsors Should Own The RTSM Vendor Relationship

  Explore how direct management of study randomization and supply chains reduces communication delays, improves system design, and protects clinical data integrity from accidental unblinding.

• What Drives Attendance And Engagement At Clinical Meetings?

  5/6/2026

  A clear look at what drives attendance and engagement at clinical meetings, and how design decisions shape comprehension, retention, and consistency as programs scale globally over time.

• How Australia's Leading CRO Is Driving Biotech's Acceleration From First-In-Human To Global Markets

  4/8/2026

  The next era of clinical trials will be defined by global expansion across the Asia-Pacific region, rapid and cost-effective pathways to regulatory approval, and reliable, patient-centric leadership.

• Why ddPCR Is Becoming The Standard For Gene Therapy Biodistribution

  3/9/2026

  ddPCR is becoming essential for biodistribution because it delivers precise, low‑copy quantification qPCR can’t reliably match. Sponsors need partners with true ddPCR depth to ensure consistent, defensible data across tissues and studies.

• Do CROs Need To Reinvent Themselves In 2025?

  3/21/2025

  Facing economic pressures, regulatory changes, and technological advancements, CROs must redefine their value propositions and discuss the need for reinvention in 2025 to accelerate into the future.

• Unlocking The Benefits Of Site Payment Platforms: Part 1

  12/5/2025

  By standardizing workflows, ensuring audit-ready documentation, and providing actionable real-time insights, these platforms mitigate operational risks while supporting better financial oversight.